ELR-CXC chemokine antagonism and cisplatin co-treatment additively reduce H22 hepatoma tumor progression and ameliorate cisplatin-induced nephrotoxicity

Author：                  

Publisher： Spandidos Publications

ISSN： 1021-335X

Source： Oncology Reports, Vol.31, Iss.4, 2014-01, pp. : 1599-1604

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

顺铂肾毒性损伤机制的研究进展 Research Advancement on Cisplatin-Induced Nephrotoxicity

By 孙章萍   曲振运   李墨林  

World Journal of Cancer Research, Vol. 02, Iss. 04, 2013-01 ,pp. : 21-26

汉斯出版社

Access to resources Recommend Favorite

NF-κB signaling plays irreplaceable roles in cisplatin-induced bladder cancer chemoresistance and tumor progression

By              

International Journal of Oncology, Vol. 48, Iss. 1, 2016-01 ,pp. : 225-234

Spandidos Publications

Access to resources Recommend Favorite

Protection Against Cisplatin-Induced Nephrotoxicity by Recombinant Human Erythropoietin

By Yalcin Suayib   Müftüoùglu Sevda   Cetúõn Eren   Süarer Banu   Yildirim Berna Akkusü   Zeybek Dúõlara   Orhan Bülent  

Medical Oncology, Vol. 20, Iss. 2, 2003-06 ,pp. : 169-174

Humana Press, Inc

Access to resources Recommend Favorite

Grape seed proanthocyanidin extract protects from cisplatin-induced nephrotoxicity by inhibiting endoplasmic reticulum stress-induced apoptosis

By              

Molecular Medicine Reports, Vol. 9, Iss. 3, 2014-01 ,pp. : 801-807

Spandidos Publications

Access to resources Recommend Favorite

G31P, CXCR1/2 inhibitor, with cisplatin inhibits the growth of mice hepatocellular carcinoma and mitigates highdose cisplatin-induced nephrotoxicity

By  

Oncology Reports, Vol. 33, Iss. 2, 2015-01 ,pp. : 751-757

Spandidos Publications

Access to resources Recommend Favorite